Member Info for WeTookPelham

I'm not sure if there was an element of sarcasm in the question there?

"I am presuming Scancell are planning theirs too.........................."

Could this be the new "immunotherapy" patent?

https://www.ft.com/content/a67d1c2e-9963-4fd0-9ba6-dc677f68a216

https://www.bbc.co.uk/news/av/health-55281633

IMO an excellent, easy to follow video about the vaccine approval process.

Edit - actually Biontech are a better comparison IMO, a cancer tech bio suddendly and strategically transferring their knowledge to virus vaccines. Look how far they got in 12 months. Yes a huge difference in budget and manpower but if Scancell/Nottingham get the same "appropriate" level of backing I don't see why it could not be replicated here?...IMO. And they've already done a lot of the initial groundwork it seems too.

@C7 - thanks, I should add that this is under the assumption initial results for SN14 are promising (don't want to accused of ramping after all;) ), but in saying that we saw with Oxford, that if backing is recieved, just how quickly things move and how tasks are run concurrently even before formal testing has started....IMO.

Just pondering, as the government have already given £2.7m for the Nottingham/Scancell consortium, there is a very good likelyhood (IMO) that further funding will be given, and soon, especially given the news about new strains popping here there and everywhere. However is it possible that Scancell (and redmile/vuples) will be thinking about partnering with a big pharma instead? In much the same way Biontech did with Pfizer, and Oxford did with Astra etc.

As cold as it sounds this would maximise both control and profits for SN14 would it not? Which I'm sure Redmile/Vulpes will be thinking about. I'm not sure if all government funded vaccines have to be sold at cost price?
And RE the £2.7m, i'm sure Scancell if they wanted to could easily now pay that back to the government if the wanted to, to the "go it alone/with a partner" so to speak? Not sure what the deal with UKRI stipulates? Is there some sort of contract/promise to deliver vaccines to the government or was it just research funds?

P.S. a related question, when we speak about Oxford in the context of their vaccine, is it the university itself, or is it a commercial arm of the university? Because Scancell is/was a commecrial offshoot of Nottingham Uni right? My point is big pharma (i.e. Astra) seem more than happy to tie in directly with the academia world?

Edit - just realised, both Oxford/Astra intrinscally tied in with UK goverment anyway, but curious to understand the arrangments between all three parties.

https://www.statnews.com/2021/01/07/coronavirus-mutation-vaccine-strength/

"Scientists are monitoring a coronavirus mutation that could affect the strength of vaccines"

https://twitter.com/MRC_LMB/status/1338419944648814592

SCANCELL Retweeted
MRC Laboratory of Molecular Biology
@MRC_LMB
Dec 14, 2020
Why N protein may be important in future #SARSCoV2 #vaccines - Latest research on #antibodies and #TRIM21 from the James lab put into context by first author
@DrSarahCaddy in this article @ConversationUK

https://theconversation.com/covid-vaccines-focus-on-the-spike-protein-but-heres-another-target-150315

"...However, the SARS-CoV-2 virus is more complicated than just a spike protein. There are, in fact, four different proteins that form the overall structure of the virus particle: spike, envelope (E), membrane (M) and nucleocapsid (N). In a natural infection, our immune system recognises all of these proteins to varying degrees. So how important are immune responses to these different proteins, and does it matter that the first vaccines will not replicate these?

Following SARS-CoV-2 infection, researchers have discovered that we actually make the most antibodies to the N protein – not the spike protein. This is the same for many different viruses that also have N proteins. But how N protein antibodies protect us from infection has been a long-standing mystery. This is because N protein is only found inside the virus particle, wrapped around the RNA. Therefore, N protein antibodies cannot block virus entry, will not be measured in neutralisation assays that test for this in the lab, and so have largely been overlooked."

An odd day? Couldn't do a dummy sell like another poster mentioned most of the afternoon (a big sell?), yet price didn't move much all day, and didn't seem too affected by the Moderna news. Thoughts?

@knowelsi - whilst my posts are generally full of unashamed rampy bias, that was a genuine question. And if anything it would be better if it was definitely a director buy perhaps? I was curious how much time was needed for it to be declared via RNS if it was a director buy.

But thanks for yet again highlighting your tactics and sleight of hand :)

...for the big buy? Maybe a private investor and not a director buy after all?

...for just 602 shares I'm being quoted atm.

https://twitter.com/thatginamiller/status/1346204854050557954

https://bylinetimes.com/2021/01/04/vaccine-minister-nadhim-zahawi-family-set-up-medical-company/

"A Family Affair
This is not the first time a Government minister has faced with scrutiny about their business links during the Coronavirus pandemic.

As revealed by Byline Times in December, a firm with links to the family of Health and Social Care Secretary Matt Han**** has been awarded a £5.5 million contract for the provision of mobile testing units. The chairman of EMS Healthcare, who has been a director of the company since 2013, is Iain Johnston – a former business partner of Shirley and Robert Carter, Han****’s mother and stepfather.

This followed a story published by the Guardian just a few weeks earlier, exposing how the Government had awarded a multi-million-pound contract for the supply of test tubes to the ex-landlord of Han****’s local pub.

Meanwhile, the business interests of Kate Bingham – outgoing chair of the UK’s vaccine task force – have been heavily scrutinised. In November, Bingham faced questions about whether she would personally benefit from a £49 million taxpayer-backed investment into a fund run by her private equity firm.

It is often been remarked that Parliament has among the greatest concentration of millionaires in the country. A large number of MPs have extensive business ties and this income is often required to fund their campaigns. However, the way this trend seems to have manifested during the pandemic is of an entirely different order of magnitude."

https://www.youtube.com/watch?v=pG0nHfcaKdY&feature=emb_title

Perefectly succint comments:
ilokivi
"To call the government of the UK a banana Republic would be insulting, as a banana Republic produces something tangible whereas the UK government is merely bent."

Martin Ross
1 day ago
"The Boiled Egg strikes again! The Tories are having a fabulously wealthy Covid. We’re dying to make them rich!"

Is this off topic? It's not even close to being off topic IMO.

https://vimeo.com/497956903

Not sure if the recording of that meeting has published yet? Not seen it myself yet.

@AB124
"Far from putting all their eggs in one basket haven't the UK GVT ordered from more than six companies already for Covid Vax? In my opinion, I am certain Scancell will get all the funding they need once they can prove the product is safe and efficacious . So I'm sure we don't have to worry too much about funding for Covidity in the appropriate circumstances."

I was referring to the UK government's backing of home-grown/uk developed vaccines, rather than all the vaccine types they had pre-ordered from around the world.
I keep referring to the fact it took four months to get the platry £2.7m, this at time when they were blowing £100's of millions on dodgy PPE contracts for mates, and countless other wasteful schemes. Purely IMO they were hedging their bets on Oxford, thinking it was all they needed, no foresight RE mutations etc. There was no rush/desire by the government to back other appraoches...IMO.
IMO, also we know how this government likes to support their freinds, associates and donors before anyone else when comes to "any" kind of government contract.

Inanaco has summed this up perfectly just now on Twitter:
"Inanaco
@Inanacouk
·
1h
Replying to @AlokSharma_RDG @OxfordVacGroup and @AstraZeneca
Don't forget the Gov Investment in Nottingham Uni, Trent Uni with Scancell regarding the Second Generation DNA vac that targets the S spike and the N protein giving protection from future variants Well Done the Conservatives for Investing in "just in case" £2.7m"

That's exactly what the funding was - "just in case" money. IMO.
Bet they wish they put more into Nottingham\Scancell now don't they...and sooner.

"We need to get this into testing ASAP and get the same level of support the AZ team received."

What I've been saying for a while, IMO the government put all there eggs in the Oxford basket, and did not seriously look at other vaccines/approaches last year when they should have been concurrently... IMO.

But I think the impact of new strains will force the hand of the government now and make them realise the Nottingham/Scancell approach has to looked at/fast tracked now. This may be why we are seeing interest in the share price this week? Something is happening now in the background. But IMO it should have happened sooner and the initial funding given much quicker.

Agree 2cvguy, plus they are fully "invested" in Oxford. However...saying that I would expect additional government/UKRI funding without them necessarily advertising it, much like the initial £2.7m.

...and at 15p...Anyone else?

A delayed 470,000 trade! A buy?